Asthma patients' perception of their disease and SABA use
Research type
Research Study
Full title
A prospective observational and cross-sectional qualitative study to characterize the patient experience of asthma and relationship with asthma treatment
IRAS ID
285053
Contact name
Jennifer Quint
Contact email
Sponsor organisation
Imperial College London
Duration of Study in the UK
0 years, 5 months, 14 days
Research summary
Over 4 million adults in the UK are currently receiving treatment for asthma. One contributing factor of poor asthma control may be the increased use and over reliance on the ‘reliever inhaler’ (bronchodilator) and underuse of the ‘preventer inhaler’ (anti-inflammatory). There has been little research on patients’ experiences relating to high reliever inhaler use.
In this study, we will investigate attitudes, beliefs, behaviours and experiences of asthma patients towards their inhaler use, with the Clinical Practice Research Datalink (CPRD), using patient surveys, focus groups and in-depth interviews. GP prescribing behaviours will also be measured through questionnaire surveys and focus groups. The main objectives of the study are two-fold:
1) to understand the relationship patients diagnosed with asthma have with their disease and their experience with treatment, and
2) to understand health care practitioners prescribing behaviours.
This will enable us to develop an approach to influence prescribing practices, leading to better healthcare resource utilization and improved asthma control. Finally the study will help us to gain better understanding of patient’s views on inhaler usage and why patterns of under use of preventer inhalers and increased use of reliever inhalers have emerged. Furthermore, we will gain better understanding of GP’s and Healthcare Professionals’ attitudes and approaches to prescribing, how these influence prescribing practices and patient behaviours.
CPRD will work with 130 research active GP practices, located within the M25 London area, who have contributed to CPRD within the last 6 months, and who are representative of those practices selected for the SABINA quantitative study.REC name
London - Bromley Research Ethics Committee
REC reference
21/PR/1438
Date of REC Opinion
22 Nov 2021
REC opinion
Further Information Favourable Opinion